MADRIGAL PHARMACEUTICALS, INC. - MDGL
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 7.0% | 1,584,843 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | PAULSON & CO. INC. | 7.5% | 1,707,522 | View |
| Dec 12, 2025 | SCHEDULE 13D/A | — | — | 22,711,420 | View |
| Dec 12, 2025 | SCHEDULE 13D/A | — | — | 22,711,420 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 8.3% | 1,842,690 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.